On march 25, 2024, Q32 Bio Inc. closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.92 USD | -0.33% | -13.94% | +137.57% |
May. 21 | Leerink Partners Starts Q32 Bio With Outperform Rating | MT |
May. 09 | Q32 Bio Inc. Provides Corporate Update | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
40.62 USD | -1.49% | -3.70% | 83.6B | ||
25.92 USD | -0.33% | -13.94% | 310M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+137.57% | 310M | |
+9.98% | 118B | |
+10.01% | 106B | |
-11.57% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.88% | 15.97B | |
+6.44% | 14.03B | |
+17.38% | 11.67B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Q32 Bio Inc. announced that it has received $42 million in funding from a group of investors